Morgan Stanley analyst Ronald Kamdem maintained a Buy rating on Lineage, Inc. (LINE – Research Report) yesterday and set a price target of $75.00.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Ronald Kamdem has given his Buy rating due to a combination of factors that suggest a positive outlook for Lineage, Inc. The company has reaffirmed its 2025 guidance, indicating confidence in its financial projections. The reaffirmation includes a stable AFFO guidance and core EBITDA, which are both in line with or slightly above consensus estimates. This stability is further supported by the company’s performance in the second quarter to date, which aligns with management’s expectations.
Moreover, Lineage, Inc. has addressed the majority of its warehousing business up for annual renegotiation, ensuring a stable pricing outlook for 2025. Approximately 45% of the company’s global warehousing revenue is tied to contracted escalators, providing a predictable revenue stream. Additionally, the company’s new business pipeline has shown signs of strengthening, which could contribute to future growth. These factors collectively underpin Ronald Kamdem’s Buy rating for Lineage, Inc.
According to TipRanks, Kamdem is a 4-star analyst with an average return of 4.8% and a 52.71% success rate. Kamdem covers the Real Estate sector, focusing on stocks such as Hudson Pacific Properties, Paramount Group, and Macerich.
In another report released on May 20, Truist Financial also maintained a Buy rating on the stock with a $60.00 price target.